From a new @TheLancet article today entitled "Health care in the USA: money has become the mission" https://t.co/jAjrsgJ5Zn

The kiss 💋 between nab-paclitaxel / gem and FOLFINIRNOX ?! ♥️ Neoadjuvant regimens combined in resectable 💉 RCT 324 pts vs. Upfront surgery median EFS 15 vs. 10 months? 🧐 Doubts about control group, but again in the direction of neoadjuvant to all! https://t.co/YCkQKFTo9k

🆕Prognostic factors for PanNEts 👥373 pts 🇫🇮 ⚠️Selection bias limited to resected tumors Long DSS⏳ 84% at 10-yr 📏Size ≥2.4 cm, ↑grade & Ki67 ➡ worse survival 🔬1 out 3 change in grade with review Is path review SOC for NETs? In @BJSurgery: https://t.co/fWjzltTa05

PUMP-2 published in JCO! HAIP chemo for intrahepatic cholangiocarcinoma #pump #CCA @FlavioRochaMD @ArndtVogel @curecc @timpawlik @DrAngelaLamarca @LorenzaRimassa @SyedAAhmad5 @JCO_ASCO https://t.co/vG6tVXEoQ8

New marker for NF-PanNETs: BEND2 fusions by @PancPathologist ⚡ 7% of cases ⬇️DFS 13% at 3y ⬇️DSS 25% at 5y ATRX-DAXX-BEND2🧬in 62% of met PanNETs Great to add markers to 🧰 in heterogeneous PanNETs! Let's keep 👀 for clinical implications & use https://t.co/QJMTHcp1i1

How many are leaving fiduciary. I have not due to concern over tampering with subsequent imaging. But not always comes up in TB

What a great choice! So proud of my friend @AGangiMD. She will do great work

Will paper be out soon?

If you’re a GI/HPB surgeon/oncologist who couldn’t make it to @ASCO 2025 & trying to scour for its ongoings online like I have been, here’s the 2 trials you’d probably be interested in with a concise breakdown: MATTERHORN, & CASSANDRA! (Also tagging ppl who are smarter than me)

As a trainee, how fast does your robotic surgical skills decay ? Should you keep practicing? @PatricioPolanc0 lab postdoc Dr. @SamyCastilloF gave an excellent and in depth analysis. 👏 👏@ricardo_nunezr @UTSW_Surgery @UTSWSurgeryLife @Surg_Education #ASE25

Fantastic @PancreasClub meeting last week! Grateful to represent the Transatlantic Robot Pancreas Consortium #TROPANC and HPB-Amsterdam @amsterdamumc @CancerCenterAms @jhatjhmi1 @HoggNDMD @AmerZureikatMD @paniccia_ale @PatricioPolanc0 @BasGrootKoerkam @MarcBesselink

Over 300 million people use a Mac every day. Yet most are still operating in beginner mode. Here are 11 powerful features your Mac can do:

@HoggNDMD @AmerZureikatMD @AnnSurgOncol 💯💯 And this study has 25 patients! Makes a big difference for patients where surgery is not possible (for number of reasons, frailty being a major one). It’s been our approach for years. Lucky that our rad onc group has a strong sbrt experience. Patients feel relieved when

This is a study we need. This question comes up all the time for older frail patients and hard to give them survival data My first study I tried to publish with @AmerZureikatMD as faculty was this. We had 16 patients and about that many journal rejections @AnnSurgOncol

Looking for @SocSurgOnc or @AHPBA trained HPB Surgeon. #HPBHeroines apply! https://t.co/eALsL7x579… @IHPBA @SSATNews @AmColSurgCancer @AcademicSurgery 🎓 Associate Professor level 🥼 Researcher 🤖 Robot experience/ ❤️er preferred ⛽️ HAI pump interest / liver ❤️er preferred

Looking for @SocSurgOnc trained General and GI surgical oncologist for non-HPB position - HIPEC, NET, Sarcoma, melanoma, etc https://t.co/RsQmo5MfkV @SAGES_Updates @AcademicSurgery @SSATNews @AmColSurgCancer 🎓 Assistant or Associate Professor level 🎓 Fresh grads welcome

@sonbol_bassam @spartelli @HalletJulie Good points, indeed, there was a paper that reported on the risk of LNMs based on tumor location and pancreatic head primaries may be more likely to metastasize... https://t.co/1YfNuPYBxG

For those interested in more on the emerging molecular predictors of recurrence and outcome, I direct you to this new review article that covers ATRX, DAXX and ALT among other things. There was a neat poster at ENETS on menin as a predictor of outcomes. https://t.co/WkaUWryESm

🚨PSA: the ALLIANCE A021806 for neoadjuvant vs adjuvant chemo in pancreas cancer is 4️⃣0️⃣ patients short of completing accrual Answer Dr Ferrone’s call: if each centre enrols 1️⃣ patient, enrolment will be complete! Lets do it! 💪

Wonderful catching up with the @uchicagosurgery @uchicagosurgres family at #SS02025 ! @talamonti_md @K_Roggin @DrSabha @spshubeck @HoggNDMD @sajkhanmd @fdahdaleh and many more